findmyKOL
Clinical trialNCT02488629TerminatedPhase 2Interventional

Study of SCB01A in Patient With Head and Neck Cancer

SponsorSynCore Biotechnology Co., Ltd.Enrollment5Head and Neck Squamous Cell Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To evaluate the safety and efficacy of SCB01A in head and neck cancer.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Taiwan
  • Keelung Chang Gung Memorial Hospital & Lovers Lake Branch

    Keelung, Taiwan

  • National Cheng Kung University Hospital

    Tainan, Taiwan

  • Mackay Memorial Hospital

    Taipei, Taiwan

  • National Taiwan University Hospital

    Taipei, Taiwan

  • Linkou Chang Gung Memorial Hospital

    Taoyuan, Taiwan

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

SCB01A
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2015
Primary completion
31 Dec 2017
Completion
31 Dec 2017
Last update posted
27 Jun 2023
Registered enrollment
5
Registry id
NCT02488629
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.